275 related articles for article (PubMed ID: 36000426)
21. The effect of renin-angiotensin-aldosterone system inhibitors on continuous and binary kidney outcomes in subgroups of patients with diabetes: a meta-analysis of randomized clinical trials.
Alsalemi N; Sadowski CA; Elftouh N; Louis M; Kilpatrick K; Houle SKD; Lafrance JP
BMC Nephrol; 2022 Apr; 23(1):161. PubMed ID: 35484505
[TBL] [Abstract][Full Text] [Related]
22. Renin-Angiotensin System Blockade and Long-term Clinical Outcomes in Kidney Transplant Recipients: A Meta-analysis of Randomized Controlled Trials.
Hiremath S; Fergusson DA; Fergusson N; Bennett A; Knoll GA
Am J Kidney Dis; 2017 Jan; 69(1):78-86. PubMed ID: 27712852
[TBL] [Abstract][Full Text] [Related]
23. A systematic review and network meta-analysis of the comparative efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension.
Dimou C; Antza C; Akrivos E; Doundoulakis I; Stabouli S; Haidich AB; Kotsis V
J Hum Hypertens; 2019 Mar; 33(3):188-201. PubMed ID: 30518809
[TBL] [Abstract][Full Text] [Related]
24. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.
Chung EY; Ruospo M; Natale P; Bolignano D; Navaneethan SD; Palmer SC; Strippoli GF
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD007004. PubMed ID: 33107592
[TBL] [Abstract][Full Text] [Related]
25. Blood pressure lowering efficacy of renin inhibitors for primary hypertension.
Musini VM; Lawrence KA; Fortin PM; Bassett K; Wright JM
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007066. PubMed ID: 28379619
[TBL] [Abstract][Full Text] [Related]
26. Renin-Angiotensin System Inhibitors and Major Cardiovascular Events after Sepsis.
Angriman F; Rosella LC; Lawler PR; Ko DT; Martin CM; Wunsch H; Scales DC
Ann Am Thorac Soc; 2023 Mar; 20(3):414-423. PubMed ID: 36251422
[No Abstract] [Full Text] [Related]
27. Pharmacological interventions for heart failure in people with chronic kidney disease.
Lunney M; Ruospo M; Natale P; Quinn RR; Ronksley PE; Konstantinidis I; Palmer SC; Tonelli M; Strippoli GF; Ravani P
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD012466. PubMed ID: 32103487
[TBL] [Abstract][Full Text] [Related]
28. Impact of renin-angiotensin system inhibitors on mortality during the COVID Pandemic among STEMI patients undergoing mechanical reperfusion: Insight from an international STEMI registry.
De Luca G; Cercek M; Okkels Jensen L; Bushljetikj O; Calmac L; Johnson T; Gracida Blancas M; Ganyukov V; Wojakowski W; von Birgelen C; IJsselmuiden A; Tuccillo B; Versaci F; Ten Berg J; Laine M; Berkout T; Casella G; Kala P; López Ledesma B; Becerra V; Padalino R; Santucci A; Carrillo X; Scoccia A; Amoroso G; Lux A; Kovarnik T; Davlouros P; Gabrielli G; Flores Rios X; Bakraceski N; Levesque S; Guiducci V; Kidawa M; Marinucci L; Zilio F; Galasso G; Fabris E; Menichelli M; Manzo S; Caiazzo G; Moreu J; Sanchis Forés J; Donazzan L; Vignali L; Teles R; Agostoni P; Bosa Ojeda F; Lehtola H; Camacho-Freiere S; Kraaijeveld A; Antti Y; Visconti G; Lozano Martínez-Luengas I; Scheller B; Alexopulos D; Moreno R; Kedhi E; Uccello G; Faurie B; Gutierrez Barrios A; Scotto Di Uccio F; Wilbert B; Cortese G; Dirksen MT; Parodi G; Verdoia M
Biomed Pharmacother; 2021 Jun; 138():111469. PubMed ID: 33740523
[TBL] [Abstract][Full Text] [Related]
29. Beta-blockers for hypertension.
Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
[TBL] [Abstract][Full Text] [Related]
30. Impact of early initiation of renin-angiotensin blockade on renal function and clinical outcomes in patients with hypertensive emergency: a retrospective cohort study.
Endo K; Hayashi K; Hara Y; Miyake A; Takano K; Horikawa T; Yoshino K; Sakai M; Kitamura K; Ito S; Imai N; Fujitani S; Suzuki T
BMC Nephrol; 2023 Mar; 24(1):68. PubMed ID: 36949416
[TBL] [Abstract][Full Text] [Related]
31. Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials.
Bangalore S; Fakheri R; Toklu B; Messerli FH
BMJ; 2016 Feb; 352():i438. PubMed ID: 26868137
[TBL] [Abstract][Full Text] [Related]
32. Early Renin-angiotensin System Blockade Improved Short-term and Longterm Renal Outcomes in Systemic Lupus Erythematosus Patients with Antiphospholipid-associated Nephropathy.
Yue C; Li G; Wen Y; Li X; Gao R
J Rheumatol; 2018 May; 45(5):655-662. PubMed ID: 29449503
[TBL] [Abstract][Full Text] [Related]
33. First-line renin-angiotensin system inhibitors vs. other first-line antihypertensive drug classes in hypertensive patients with type 2 diabetes mellitus.
Wang G; Chen Y; Li L; Tang W; Wright JM
J Hum Hypertens; 2018 Jul; 32(7):494-506. PubMed ID: 29713053
[TBL] [Abstract][Full Text] [Related]
34. Renin-angiotensin-aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis.
Ssentongo AE; Ssentongo P; Heilbrunn ES; Lekoubou A; Du P; Liao D; Oh JS; Chinchilli VM
Open Heart; 2020 Nov; 7(2):. PubMed ID: 33154144
[TBL] [Abstract][Full Text] [Related]
35. Association of Acute Increases in Plasma Creatinine after Renin-Angiotensin Blockade with Subsequent Outcomes.
Fu EL; Trevisan M; Clase CM; Evans M; Lindholm B; Rotmans JI; van Diepen M; Dekker FW; Carrero JJ
Clin J Am Soc Nephrol; 2019 Sep; 14(9):1336-1345. PubMed ID: 31395593
[TBL] [Abstract][Full Text] [Related]
36. Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis.
Bang CN; Greve AM; Køber L; Rossebø AB; Ray S; Boman K; Nienaber CA; Devereux RB; Wachtell K
Int J Cardiol; 2014 Aug; 175(3):492-8. PubMed ID: 25012498
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness and Tolerance of Renin-Angiotensin System Inhibitors With Aging in Chronic Kidney Disease.
Villain C; Metzger M; Liabeuf S; Hamroun A; Laville S; Mansencal N; Combe C; Fouque D; Frimat L; Jacquelinet C; Laville M; Ayav C; Briançon S; Pecoits-Filho R; Hannedouche T; Stengel B; Massy ZA;
J Am Med Dir Assoc; 2022 Jun; 23(6):998-1004.e7. PubMed ID: 34856172
[TBL] [Abstract][Full Text] [Related]
38. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
[TBL] [Abstract][Full Text] [Related]
39. RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies.
COVID-19 RISk and Treatments (CORIST) Collaboration
Vascul Pharmacol; 2020 Dec; 135():106805. PubMed ID: 32992048
[TBL] [Abstract][Full Text] [Related]
40. Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.
Wu HY; Huang JW; Lin HJ; Liao WC; Peng YS; Hung KY; Wu KD; Tu YK; Chien KL
BMJ; 2013 Oct; 347():f6008. PubMed ID: 24157497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
